adenine has been researched along with daunorubicin in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (58.82) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Drummond, KN; Kaplan, BS; Renaud, L | 1 |
| Phillips, DR; Reiss, JA; Skorobogaty, A; White, RJ | 1 |
| Krishna, G; Reese, JB; Shirhatti, V; Singh, Y | 1 |
| Henderson, JF; Snyder, FF | 1 |
| Fiil, N; Friesen, JD | 1 |
| Friesen, JD; Tonnesen, T | 2 |
| Baxter, L; Firtel, RA; Lodish, HF | 1 |
| Dano, K; Frederiksen, S; Hellung-Larsen, P | 1 |
| Calendi, E; Rusconi, A | 1 |
| Tallman, M | 1 |
| Alameh, G; Dumontet, C; Grenot, C; Radix, S; Walchshofer, N; Zeinyeh, W | 1 |
| Barret, R; Dumontet, C; Dumoulin, A; Grenot, C; Lomberget, T; Mahiout, Z; Matera, EL; Radix, S; Rocheblave, L; Walchshofer, N; Zeinyeh, W | 1 |
| Allen, SL; Damon, L; Egyed, M; Erba, HP; Horst, HA; Jang, JH; Lundberg, AS; Masszi, T; Mazzola, E; Neuberg, D; Pigneux, A; Powell, B; Rizzieri, D; Sekeres, MA; Selleslag, D; Solomon, SR; Stone, RM; Stuart, RK; Tallman, MS; Venugopal, P; Warzocha, K; Wetzler, M | 1 |
| Abdul-Aziz, A; Bowles, KM; Lawes, M; MacEwan, DJ; Pillinger, G; Rushworth, SA; Zaitseva, L | 1 |
| Gronda, M; Hurren, R; Minden, MD; Rotin, LE; Schimmer, AD; Slassi, M; Wang, X | 1 |
1 trial(s) available for adenine and daunorubicin
| Article | Year |
|---|---|
Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia.
Topics: Adenine; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Administration Schedule; Female; Humans; Induction Chemotherapy; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged; Naphthalimides; Organophosphonates; Prospective Studies; Remission Induction; Time Factors; Treatment Outcome; Young Adult | 2015 |
16 other study(ies) available for adenine and daunorubicin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effects of aminonucleoside, daunomycin, and adriamycin on carbon oxidation by glomeruli.
Topics: Adenine; Animals; Blood Proteins; Carbon Dioxide; Carbon Radioisotopes; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug Antagonism; Glucose; Glutamine; Hypercholesterolemia; Kidney Glomerulus; Male; Nephrotic Syndrome; Oxidation-Reduction; Proteinuria; Puromycin; Puromycin Aminonucleoside; Pyruvates; Rats | 1976 |
The 5'-CA DNA-sequence preference of daunomycin.
Topics: Adenine; Base Sequence; Cytosine; Daunorubicin; Deoxyribonuclease I; DNA; DNA Restriction Enzymes; DNA-Directed RNA Polymerases; Escherichia coli; Plasmids; Structure-Activity Relationship; Transcription, Genetic | 1988 |
Daunomycin inhibits the uptake of adenine, amino acids, and glucose into cardiac myocytes.
Topics: Adenine; Amino Acids; Animals; Daunorubicin; Deoxyglucose; Doxorubicin; Glucose; Heart; Methionine; Myocardium; Rats; Rats, Inbred Strains | 1987 |
Effects of actinomycin D on purine ribonucleotide metabolism in Ehrlich ascites tumor cells in vitro.
Topics: Adenine; Animals; Carbon Radioisotopes; Carcinoma, Ehrlich Tumor; Dactinomycin; Daunorubicin; Hypoxanthines; Inosine Nucleotides; Ketone Oxidoreductases; Mice; Pentosephosphates; Pentosyltransferases; Phosphoric Acids; Purine Nucleotides; Ribonucleotides; RNA; Time Factors | 1974 |
Accumulation of guanosine tetraphosphate in T7 bacteriophage-infected Escherichia coli.
Topics: Adenine; Amino Acyl-tRNA Synthetases; Carbon Isotopes; Chloramphenicol; Chromatography, Thin Layer; Coliphages; Daunorubicin; Escherichia coli; Guanine Nucleotides; Leucine; Mutation; Phosphorus Isotopes; Rifampin; RNA Viruses; RNA, Bacterial; Temperature; Transcription, Genetic; Tritium; Valine | 1973 |
Inhibitors of ribonucleic acid synthesis in Saccharomyces cerevisiae: decay rate of messenger ribonucleic acid.
Topics: Adenine; Carbon Isotopes; Daunorubicin; Ethidium; Fungal Proteins; Leucine; Mutation; Phenanthridines; Protein Biosynthesis; RNA; RNA, Messenger; Saccharomyces cerevisiae; Temperature; Time Factors; Transcription, Genetic; Tritium | 1973 |
The effects of daunomycin and ethidium bromide on Escherichia coli.
Topics: Adenine; Bacterial Proteins; Bromides; Carbon Radioisotopes; Chromosome Mapping; Dactinomycin; Daunorubicin; DNA Replication; DNA, Bacterial; Escherichia coli; Ethidium; Leucine; Mitomycins; Mutation; Protein Biosynthesis; Rifampin; RNA, Bacterial; RNA, Messenger; Time Factors; Tosyl Compounds; Transcription, Genetic; Tritium | 1973 |
Actinomycin D and the regulation of enzyme biosynthesis during development of Dictyostelium discoideum.
Topics: Adenine; Alkaline Phosphatase; Cell Differentiation; Centrifugation, Density Gradient; Dactinomycin; Daunorubicin; Fungal Proteins; Glucose; Hexosaminidases; Isotope Labeling; Myxomycetes; Nucleotidyltransferases; Phosphorus Radioisotopes; Poly U; Protein Biosynthesis; RNA, Messenger; RNA, Ribosomal; Time Factors; Tritium; Ultrafiltration; Uridine Diphosphate Sugars | 1973 |
Inhibition of DNA and RNA synthesis by daunorubicin in sensitive and resistant Ehrlich ascites tumor cells in vitro.
Topics: Adenine; Animals; Carbon Isotopes; Carcinoma, Ehrlich Tumor; Cells, Cultured; Daunorubicin; DNA, Neoplasm; Drug Resistance; Humans; In Vitro Techniques; RNA; RNA, Neoplasm; Thymidine; Time Factors; Tritium; Uridine | 1972 |
Action of daunomycin on nucleic acid metabolism in HeLa cells.
Topics: Adenine; Centrifugation; Culture Techniques; Dactinomycin; Daunorubicin; DNA; HeLa Cells; RNA | 1966 |
Existing and emerging therapeutic options for the treatment of acute myeloid leukemia.
Topics: Adenine; Adenine Nucleotides; Aminoglycosides; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Arabinonucleosides; Carbazoles; Clofarabine; Cytarabine; Dasatinib; Daunorubicin; fms-Like Tyrosine Kinase 3; Furans; Gemtuzumab; Humans; Leukemia, Myeloid, Acute; Naphthalimides; Organophosphonates; Prognosis; Protein Kinase Inhibitors; Pyrimidines; Sesquiterpenes; Staurosporine; Stem Cell Transplantation; Thiazoles; Tretinoin | 2008 |
Design, synthesis and evaluation of progesterone-adenine hybrids as bivalent inhibitors of P-glycoprotein-mediated multidrug efflux.
Topics: Adenine; Antibiotics, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Cell Line, Tumor; Daunorubicin; Drug Design; Humans; Progesterone | 2010 |
Progesterone-adenine hybrids as bivalent inhibitors of P-glycoprotein-mediated multidrug efflux: design, synthesis, characterization and biological evaluation.
Topics: Adenine; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Chemistry Techniques, Synthetic; Daunorubicin; Drug Design; Drug Resistance, Multiple; Humans; Progesterone | 2012 |
Targeting BTK for the treatment of FLT3-ITD mutated acute myeloid leukemia.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Apoptosis; Blast Crisis; Cell Line, Tumor; Cell Survival; Daunorubicin; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Mutation; Piperidines; Protein Structure, Tertiary; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; RNA, Small Interfering; Signal Transduction | 2015 |
Investigating the synergistic mechanism between ibrutinib and daunorubicin in acute myeloid leukemia cells.
Topics: Adenine; Cytarabine; Daunorubicin; Leukemia, Myeloid, Acute; Piperidines; Pyrazoles; Pyrimidines | 2016 |